GSK ROA 2010-2022 | GSK

Current and historical return on assets (ROA) values for GSK (GSK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
GSK ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-06-30 $6.07B $111.80B 5.40%
2022-03-31 $6.97B $120.35B 6.26%
2021-12-31 $6.03B $108.78B 5.58%
2021-09-30 $6.00B $108.50B 5.62%
2021-06-30 $6.00B $107.65B 5.67%
2021-03-31 $6.86B $107.67B 6.52%
2020-12-31 $7.38B $103.27B 7.01%
2020-09-30 $8.12B $104.54B 7.74%
2020-06-30 $8.42B $105.03B 8.07%
2020-03-31 $6.86B $108.09B 6.95%
2019-12-31 $5.93B $101.76B 6.46%
2019-09-30 $5.56B $102.65B 6.48%
2019-06-30 $5.49B $81.81B 6.93%
2019-03-31 $4.85B $81.23B 6.19%
2018-12-31 $4.84B $77.51B 6.23%
2018-09-30 $2.83B $76.36B 3.71%
2018-06-30 $2.57B $78.44B 3.36%
2018-03-31 $1.74B $78.15B 2.31%
2017-12-31 $1.98B $72.66B 2.66%
2017-09-30 $2.97B $76.96B 3.90%
2017-06-30 $2.45B $74.47B 3.21%
2017-03-31 $2.05B $73.37B 2.62%
2016-12-31 $1.16B $80.07B 1.46%
2016-09-30 $0.30B $77.21B 0.38%
2016-06-30 $0.07B $82.69B 0.09%
2016-03-31 $0.93B $78.06B 1.14%
2015-12-31 $12.77B $81.72B 15.25%
2015-09-30 $14.87B $82.36B 18.57%
2015-06-30 $14.68B $82.89B 19.24%
2015-03-31 $15.57B $87.93B 21.65%
2014-12-31 $4.44B $67.00B 6.69%
2014-09-30 $6.81B $67.35B 10.30%
2014-06-30 $7.73B $65.39B 11.86%
2014-03-31 $8.22B $65.72B 12.65%
2013-12-31 $8.56B $65.86B 13.13%
2013-09-30 $6.01B $63.72B 9.22%
2013-06-30 $6.25B $64.61B 9.58%
2013-03-31 $6.62B $66.64B 10.05%
2012-12-31 $7.30B $65.74B 11.18%
2012-09-30 $7.90B $63.91B 12.10%
2012-06-30 $8.28B $67.24B 12.55%
2012-03-31 $8.10B $64.10B 12.21%
2011-12-31 $8.41B $65.91B 12.48%
2011-09-30 $5.32B $66.75B 7.92%
2011-06-30 $5.21B $68.67B 7.78%
2011-03-31 $2.98B $68.17B 4.52%
2010-12-31 $2.60B $65.03B 3.92%
2010-09-30 $6.44B $66.10B 9.64%
2010-06-30 $6.60B $64.23B 9.82%
2010-03-31 $9.29B $69.57B 14.27%
2009-12-31 $8.92B $67.12B 14.43%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $61.844B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $152.564B 9.26
Bio-Rad Laboratories (BIO.B) United States $13.545B 29.93
QIAGEN (QGEN) Netherlands $9.898B 16.57
Ginkgo Bioworks Holdings (DNA) United States $5.908B 0.00
Myovant Sciences (MYOV) United Kingdom $2.391B 0.00
Arcus Biosciences (RCUS) United States $2.007B 39.18
Emergent Biosolutions (EBS) United States $1.039B 6.02
Biohaven Pharmaceutical Holding (BHVN) United States $0.878B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.392B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Enzo Biochem (ENZ) United States $0.113B 0.00
Gelesis Holdings (GLS) United States $0.087B 0.00
SQZ Biotechnologies (SQZ) United States $0.075B 0.00
Ambrx Biopharma (AMAM) United States $0.045B 0.00